News
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma. Eur Urol. 2016 May;69 (5):767-70. doi: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback